Recurrent Cutaneous T-cell lymphoma

Also known as: Recurrent T-Cell Lymphoma / Relapsed T-Cell Lymphoma / T-Cell Lymphoma Relapsed / T-cell lymphoma recurrent / T-cell lymphoma NOS recurrent

DrugDrug NameDrug Description
DB02546VorinostatA histone deacetylase (HDAC) inhibitor used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies.
DrugDrug NamePhaseStatusCount
DB00023Asparaginase Escherichia coli0Terminated1
DB14649Dexamethasone acetate0Terminated1
DB00059Pegaspargase0Terminated1
DB00087Alemtuzumab1Active Not Recruiting1
DB11945Avelumab2Active Not Recruiting1
DB06769Bendamustine2Recruiting1
DB01008Busulfan2Active Not Recruiting1
DB00531Cyclophosphamide2Active Not Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB09331Daratumumab2Not Yet Recruiting1
DB00099Filgrastim2Active Not Recruiting1
DB01073Fludarabine2Active Not Recruiting1
DB01073Fludarabine2Recruiting2
DB01042Melphalan2Active Not Recruiting1
DB01042Melphalan2Recruiting1
DB00688Mycophenolate mofetil2Active Not Recruiting1
DB00688Mycophenolate mofetil2Recruiting1
DB00877Sirolimus2Recruiting1
DB00864Tacrolimus2Active Not Recruiting1
DB11581Venetoclax2Active Not Recruiting1
DB06813Pralatrexate3Completed1